NTS2 receptor (ntr2_rat)
FAMILY
Class A (Rhodopsin) Peptide receptors Neurotensin receptors NTS2 receptor
GENE
Ntsr2 (Ntr2)
ORGANISM
Rat (Rattus norvegicus)
ALT. NAMES
Neurotensin receptor type 2, NT-R-2, NTR2, High-affinity levocabastine-sensitive neurotensin receptor
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
E
|
T
|
S
|
S
|
P
|
W
|
P
|
P
|
R
|
10 |
P
|
S
|
P
|
S
|
A
|
G
|
L
|
S
|
L
|
E
|
20 |
A
|
R
|
L
|
G
|
V
|
D
|
T
|
R
|
L
|
W
|
30 |
TM1 | |||||||||
A
|
K
|
V
|
L
|
F
|
T
|
A
|
L
|
Y
|
S
|
40 |
L
|
I
|
F
|
A
|
F
|
G
|
T
|
A
|
G
|
N
|
50 |
A
|
L
|
S
|
V
|
H
|
V
|
V
|
L
|
K
|
A
|
60 |
ICL1 | TM2 | ||||||||
R
|
A
|
G
|
R
|
P
|
G
|
R
|
L
|
R
|
Y
|
70 |
H
|
V
|
L
|
S
|
L
|
A
|
L
|
S
|
A
|
L
|
80 |
L
|
L
|
L
|
L
|
V
|
S
|
M
|
P
|
M
|
E
|
90 |
L
|
Y
|
N
|
F
|
V
|
W
|
S
|
H
|
Y
|
P
|
100 |
ECL1 | TM3 | ||||||||
W
|
V
|
F
|
G
|
D
|
L
|
G
|
C
|
R
|
G
|
110 |
Y
|
Y
|
F
|
V
|
R
|
E
|
L
|
C
|
A
|
Y
|
120 |
A
|
T
|
V
|
L
|
S
|
V
|
A
|
S
|
L
|
S
|
130 |
A
|
E
|
R
|
C
|
L
|
A
|
V
|
C
|
Q
|
P
|
140 |
ICL2 | TM4 | ||||||||
L
|
R
|
A
|
R
|
R
|
L
|
L
|
T
|
P
|
R
|
150 |
R
|
T
|
R
|
R
|
L
|
L
|
S
|
L
|
V
|
W
|
160 |
V
|
A
|
S
|
L
|
G
|
L
|
A
|
L
|
P
|
M
|
170 |
ECL2 | |||||||||
A
|
V
|
I
|
M
|
G
|
Q
|
K
|
H
|
E
|
V
|
180 |
E
|
S
|
A
|
D
|
G
|
E
|
P
|
E
|
P
|
A
|
190 |
S
|
R
|
V
|
C
|
T
|
V
|
L
|
V
|
S
|
R
|
200 |
TM5 | |||||||||
A
|
T
|
L
|
Q
|
V
|
F
|
I
|
Q
|
V
|
N
|
210 |
V
|
L
|
V
|
S
|
F
|
A
|
L
|
P
|
L
|
A
|
220 |
L
|
T
|
A
|
F
|
L
|
N
|
G
|
I
|
T
|
V
|
230 |
N
|
H
|
L
|
M
|
A
|
L
|
Y
|
S
|
Q
|
V
|
240 |
ICL3 | |||||||||
P
|
S
|
A
|
S
|
A
|
Q
|
V
|
S
|
S
|
I
|
250 |
P
|
S
|
R
|
L
|
E
|
L
|
L
|
S
|
E
|
E
|
260 |
G
|
L
|
L
|
G
|
F
|
I
|
T
|
W
|
R
|
K
|
270 |
T
|
L
|
S
|
L
|
G
|
V
|
Q
|
A
|
S
|
L
|
280 |
TM6 | |||||||||
V
|
R
|
H
|
K
|
D
|
A
|
S
|
Q
|
I
|
R
|
290 |
S
|
L
|
Q
|
H
|
S
|
A
|
Q
|
V
|
L
|
R
|
300 |
A
|
I
|
V
|
A
|
V
|
Y
|
V
|
I
|
C
|
W
|
310 |
L
|
P
|
Y
|
H
|
A
|
R
|
R
|
L
|
M
|
Y
|
320 |
ECL3 | |||||||||
C
|
Y
|
I
|
P
|
D
|
D
|
G
|
W
|
T
|
N
|
330 |
TM7 | |||||||||
E
|
L
|
Y
|
D
|
F
|
Y
|
H
|
Y
|
F
|
Y
|
340 |
M
|
V
|
T
|
N
|
T
|
L
|
F
|
Y
|
V
|
S
|
350 |
S
|
A
|
V
|
T
|
P
|
I
|
L
|
Y
|
N
|
A
|
360 |
H8 | |||||||||
V
|
S
|
S
|
S
|
F
|
R
|
K
|
L
|
F
|
L
|
370 |
E
|
S
|
L
|
G
|
S
|
L
|
C
|
G
|
E
|
Q
|
380 |
C-term | |||||||||
H
|
S
|
L
|
V
|
P
|
L
|
P
|
Q
|
E
|
A
|
390 |
P
|
E
|
S
|
T
|
T
|
S
|
T
|
Y
|
S
|
F
|
400 |
R
|
L
|
W
|
G
|
S
|
P
|
R
|
N
|
P
|
S
|
410 |
L
|
G
|
E
|
I
|
Q
|
V
|
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
neuromedin N, neurotensin
STRUCTURE MODELS
No structure models available. Check the Archive on Structure models for earlier releases.
STRUCTURES
No structures available